Cabaletta Bio is trading 5.25% higher at $2.10 on October 5, 2026, with broader market strength the clearest available context for the gain.
- The S&P 500 was up 0.6% and the Nasdaq rose 0.9% amid buying in growth stocks.
- No new company-specific announcement explaining the move appeared in available search results; the company’s press-release page was last updated October 2.